HUP0102455A3 - Novel nucleic acid transfer agents, compositions containing same and uses - Google Patents
Novel nucleic acid transfer agents, compositions containing same and usesInfo
- Publication number
- HUP0102455A3 HUP0102455A3 HU0102455A HUP0102455A HUP0102455A3 HU P0102455 A3 HUP0102455 A3 HU P0102455A3 HU 0102455 A HU0102455 A HU 0102455A HU P0102455 A HUP0102455 A HU P0102455A HU P0102455 A3 HUP0102455 A3 HU P0102455A3
- Authority
- HU
- Hungary
- Prior art keywords
- nucleic acid
- compositions containing
- transfer agents
- containing same
- novel nucleic
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/12—Nitrogen atoms not forming part of a nitro radical
- C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9804121A FR2777017B1 (en) | 1998-04-02 | 1998-04-02 | NOVEL NUCLEIC ACID TRANSFER AGENTS, COMPOSITIONS CONTAINING THEM AND USES THEREOF |
| US8584598P | 1998-05-18 | 1998-05-18 | |
| PCT/FR1999/000740 WO1999051581A1 (en) | 1998-04-02 | 1999-03-30 | Novel nucleic acid transfer agents, compositions containing same and uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0102455A2 HUP0102455A2 (en) | 2001-10-28 |
| HUP0102455A3 true HUP0102455A3 (en) | 2003-09-29 |
Family
ID=26234240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0102455A HUP0102455A3 (en) | 1998-04-02 | 1999-03-30 | Novel nucleic acid transfer agents, compositions containing same and uses |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1068188A1 (en) |
| JP (1) | JP2002513543A (en) |
| KR (1) | KR20010042318A (en) |
| CN (1) | CN1294582A (en) |
| AU (1) | AU759301B2 (en) |
| BR (1) | BR9909350A (en) |
| CA (1) | CA2324931A1 (en) |
| HU (1) | HUP0102455A3 (en) |
| IL (1) | IL138625A0 (en) |
| NO (1) | NO317225B1 (en) |
| PL (1) | PL342886A1 (en) |
| WO (1) | WO1999051581A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020091242A1 (en) | 2000-10-11 | 2002-07-11 | Michel Bessodes | Acid-sensitive compounds, their preparation and uses |
| ITMI20050222A1 (en) * | 2005-02-15 | 2006-08-16 | Milano Politecnico | CATION LIPIDS FOR THE TRANSFORMATION OF NUCLEIC ACIDS |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2645866B1 (en) * | 1989-04-17 | 1991-07-05 | Centre Nat Rech Scient | NEW LIPOPOLYAMINES, THEIR PREPARATION AND THEIR USE |
| US5283185A (en) * | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
| FR2714830B1 (en) * | 1994-01-10 | 1996-03-22 | Rhone Poulenc Rorer Sa | Composition containing nucleic acids, preparation and uses. |
| FR2727679B1 (en) * | 1994-12-05 | 1997-01-03 | Rhone Poulenc Rorer Sa | NEW TRANSFECTION AGENTS AND THEIR PHARMACEUTICAL APPLICATIONS |
| FR2741066B1 (en) * | 1995-11-14 | 1997-12-12 | Rhone Poulenc Rorer Sa | NEW TRANSFECTION AGENTS AND THEIR PHARMACEUTICAL APPLICATIONS |
| IL125926A (en) * | 1996-03-01 | 2004-09-27 | Centre Nat Rech Scient | Compounds related to the amidinium family, pharmaceutical compositions containing same and uses thereof |
-
1999
- 1999-03-30 IL IL13862599A patent/IL138625A0/en unknown
- 1999-03-30 BR BR9909350-2A patent/BR9909350A/en not_active IP Right Cessation
- 1999-03-30 CA CA002324931A patent/CA2324931A1/en not_active Abandoned
- 1999-03-30 EP EP99910463A patent/EP1068188A1/en not_active Withdrawn
- 1999-03-30 KR KR1020007010867A patent/KR20010042318A/en not_active Application Discontinuation
- 1999-03-30 WO PCT/FR1999/000740 patent/WO1999051581A1/en not_active Application Discontinuation
- 1999-03-30 PL PL99342886A patent/PL342886A1/en not_active Application Discontinuation
- 1999-03-30 HU HU0102455A patent/HUP0102455A3/en unknown
- 1999-03-30 CN CN99804274A patent/CN1294582A/en active Pending
- 1999-03-30 JP JP2000542302A patent/JP2002513543A/en not_active Withdrawn
-
2000
- 2000-05-12 AU AU34061/00A patent/AU759301B2/en not_active Ceased
- 2000-09-25 NO NO20004780A patent/NO317225B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20004780L (en) | 2000-11-01 |
| BR9909350A (en) | 2000-12-12 |
| JP2002513543A (en) | 2002-05-14 |
| NO20004780D0 (en) | 2000-09-25 |
| EP1068188A1 (en) | 2001-01-17 |
| CA2324931A1 (en) | 1999-10-14 |
| HUP0102455A2 (en) | 2001-10-28 |
| WO1999051581A1 (en) | 1999-10-14 |
| AU3406100A (en) | 2000-11-30 |
| KR20010042318A (en) | 2001-05-25 |
| CN1294582A (en) | 2001-05-09 |
| NO317225B1 (en) | 2004-09-20 |
| PL342886A1 (en) | 2001-07-16 |
| IL138625A0 (en) | 2001-10-31 |
| AU759301B2 (en) | 2003-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2105999A (en) | Novel quaternary ammonium compounds, compositions containing them, and uses thereof | |
| PL341372A1 (en) | Cellecoxibe containing compositions | |
| HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
| HUP0102483A3 (en) | Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol | |
| HUP0203505A3 (en) | 2'-substituted 1,1'-biphenyl-2-carbonamides, and pharmaceutical compositions containing said compounds | |
| PL338186A1 (en) | Beneficial agent compositions containing alpha-hydroxyesters | |
| HUP0000762A3 (en) | 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them | |
| IL162274A (en) | Nucleic acid and protein designated 193p1e1b and compositions containing the same | |
| HUP0004375A3 (en) | Composition containing azelaic acid | |
| PL339920A1 (en) | Synergetic compositions comprising oxathiazine and benzothiophene-2-carboxamido-s,s-dioxide | |
| PL342944A1 (en) | Nucleic acid transfer vectors, compositions containing same and uses | |
| GB9814205D0 (en) | Refactory compositions | |
| EP1208268A4 (en) | Novel quaternary compounds, compositions containing them, and uses thereof | |
| HUP0200345A3 (en) | Novel nucleic acid transferring agents, compositions containing them and uses | |
| GB9704643D0 (en) | Chemical composition | |
| PL342165A1 (en) | Antienzymic composition containing ethylenediamino disuscinic acid | |
| PL342886A1 (en) | Novel nucleic acid transfer agents, compositions containing same and uses | |
| GB9923882D0 (en) | Chemical composition | |
| GB9715908D0 (en) | Chemical composition | |
| ZA992262B (en) | Vectors for transferring nucleic acids, compositions containing them and their uses. | |
| HUP0103006A3 (en) | Substituted betha-diketones, pharmaceutical compositions containing them and their use | |
| HK1043479A1 (en) | Biological compositions, components thereof and uses therefor | |
| GB9819600D0 (en) | Chemical compositions | |
| PL319742A1 (en) | Novel compound, pharmaceutic compositions containing same and application thereof | |
| IL142278A0 (en) | Imidazo-isoquinoline compounds, their compositions and uses |